Your browser doesn't support javascript.
loading
The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma.
Lee, Shou-Wu; Yang, Sheng-Shun; Lien, Han-Chung; Peng, Yen-Chun; Tung, Chun-Fang; Lee, Teng-Yu.
Affiliation
  • Lee SW; Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
  • Yang SS; Department of Internal Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
  • Lien HC; Department of Internal Medicine, Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
  • Peng YC; Department of Post-Baccalaureate Medicine, College of Medicine, Chung Hsing University, Taichung 40227, Taiwan.
  • Tung CF; Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
  • Lee TY; Department of Internal Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
J Clin Med ; 11(16)2022 Aug 19.
Article in En | MEDLINE | ID: mdl-36013120
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2022 Document type: Article Affiliation country: Taiwan Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2022 Document type: Article Affiliation country: Taiwan Country of publication: Switzerland